These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 24813595)
1. Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial. Kort DH; Lobo RA Am J Obstet Gynecol; 2014 Nov; 211(5):487.e1-6. PubMed ID: 24813595 [TBL] [Abstract][Full Text] [Related]
2. The effect of cinnamon on polycystic ovary syndrome in a mouse model. Dou L; Zheng Y; Li L; Gui X; Chen Y; Yu M; Guo Y Reprod Biol Endocrinol; 2018 Oct; 16(1):99. PubMed ID: 30340496 [TBL] [Abstract][Full Text] [Related]
3. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study. Wang JG; Anderson RA; Graham GM; Chu MC; Sauer MV; Guarnaccia MM; Lobo RA Fertil Steril; 2007 Jul; 88(1):240-3. PubMed ID: 17296187 [TBL] [Abstract][Full Text] [Related]
4. Insulin resistance improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled clinical trial. Hajimonfarednejad M; Nimrouzi M; Heydari M; Zarshenas MM; Raee MJ; Jahromi BN Phytother Res; 2018 Feb; 32(2):276-283. PubMed ID: 29250843 [TBL] [Abstract][Full Text] [Related]
5. Cinnamon improves metabolic factors without detectable effects on adiponectin in women with polycystic ovary syndrome. Borzoei A; Rafraf M; Asghari-Jafarabadi M Asia Pac J Clin Nutr; 2018; 27(3):556-563. PubMed ID: 29737802 [TBL] [Abstract][Full Text] [Related]
6. Early effects of metformin in women with polycystic ovary syndrome: a prospective randomized, double-blind, placebo-controlled trial. Eisenhardt S; Schwarzmann N; Henschel V; Germeyer A; von Wolff M; Hamann A; Strowitzki T J Clin Endocrinol Metab; 2006 Mar; 91(3):946-52. PubMed ID: 16352680 [TBL] [Abstract][Full Text] [Related]
7. The chronic administration of cabergoline normalizes androgen secretion and improves menstrual cyclicity in women with polycystic ovary syndrome. Paoletti AM; Cagnacci A; Depau GF; Orrù M; Ajossa S; Melis GB Fertil Steril; 1996 Oct; 66(4):527-32. PubMed ID: 8816612 [TBL] [Abstract][Full Text] [Related]
8. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial. Fux Otta C; Wior M; Iraci GS; Kaplan R; Torres D; Gaido MI; Wyse EP Gynecol Endocrinol; 2010 Mar; 26(3):173-8. PubMed ID: 20148739 [TBL] [Abstract][Full Text] [Related]
10. Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome. Lucidi RS; Thyer AC; Easton CA; Holden AE; Schenken RS; Brzyski RG Fertil Steril; 2005 Dec; 84(6):1755-7. PubMed ID: 16359984 [TBL] [Abstract][Full Text] [Related]
11. Effects of zinc supplementation on markers of insulin resistance and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Foroozanfard F; Jamilian M; Jafari Z; Khassaf A; Hosseini A; Khorammian H; Asemi Z Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):215-20. PubMed ID: 25868059 [TBL] [Abstract][Full Text] [Related]
12. Metformin treatment is effective in obese teenage girls with PCOS. De Leo V; Musacchio MC; Morgante G; Piomboni P; Petraglia F Hum Reprod; 2006 Sep; 21(9):2252-6. PubMed ID: 16785260 [TBL] [Abstract][Full Text] [Related]
13. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome. Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907 [TBL] [Abstract][Full Text] [Related]
14. Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Tang T; Glanville J; Hayden CJ; White D; Barth JH; Balen AH Hum Reprod; 2006 Jan; 21(1):80-9. PubMed ID: 16199429 [TBL] [Abstract][Full Text] [Related]
15. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial. Gerli S; Mignosa M; Di Renzo GC Eur Rev Med Pharmacol Sci; 2003; 7(6):151-9. PubMed ID: 15206484 [TBL] [Abstract][Full Text] [Related]
16. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome]. Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058 [TBL] [Abstract][Full Text] [Related]
17. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations. Koo YA; Shin SY; Yoon BK; Choi D Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial. Irani M; Seifer DB; Grazi RV; Julka N; Bhatt D; Kalgi B; Irani S; Tal O; Lambert-Messerlian G; Tal R J Clin Endocrinol Metab; 2015 Nov; 100(11):4307-14. PubMed ID: 26485217 [TBL] [Abstract][Full Text] [Related]
19. Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: secondary analysis of a randomized controlled trial. Nybacka Å; Carlström K; Fabri F; Hellström PM; Hirschberg AL Fertil Steril; 2013 Oct; 100(4):1096-102. PubMed ID: 23876536 [TBL] [Abstract][Full Text] [Related]
20. Effects of selenium supplementation on glucose homeostasis and free androgen index in women with polycystic ovary syndrome: A randomized, double blinded, placebo controlled clinical trial. Mohammad Hosseinzadeh F; Hosseinzadeh-Attar MJ; Yekaninejad MS; Rashidi B J Trace Elem Med Biol; 2016 Mar; 34():56-61. PubMed ID: 26854246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]